¼º¼®ÁÖ
¼Ò
¼Ó
: °³²Â÷º´¿ø
Àü¹®ºÐ¾ß : ºÎÀξÏ, ÀڱñÙÁ¾, ³¼ÒÁ¾¾ç,·Îº¿¼ö¼ú, º¹°°æ,Àڱðæ, ´ÜÀÏ°ø¼ö¼ú
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
.
Àü
È
:
02.3468.3000
ÆÑ
½º
:
02.558.1119
ÁÖ
¼Ò
:
¼¿ï½Ã °³²±¸ ¿ª»ï1µ¿ 650-9
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
104
ÇØ¿Ü
Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
103
ÇØ¿Ü
Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
102
ÇØ¿Ü
Multi-Institution, prospective randomized trial to compare the success rates of single-port versus multi-port laparoscopic hysterectomy for the treatment of uterine myoma or adenomyosis.
101
ÇØ¿Ü
A Randomized Comparison of Laparoendoscopic Single-Site Hysterectomies: Total Laparoscopic Hysterectomy Versus Laparoscopically Assisted Vaginal Hysterectomy.
100
ÇØ¿Ü
Ovarian-sparing local mass excision for ovarian fibroma/fibrothecoma in premenopausal women.
99
ÇØ¿Ü
Operative outcomes of single-port-access laparoscopy-assisted vaginal hysterectomy compared with single-port-access total laparoscopic hysterectomy.
98
ÇØ¿Ü
Laparoscopic salpingotomy using the floseal hemostatic sealant in patients with tubal pregnancy.
97
ÇØ¿Ü
Laparoendoscopic Single-Site Surgery for Extremely Large Ovarian Cysts: A Feasibility, Safety, and Patient Satisfaction Study.
96
ÇØ¿Ü
Effectiveness of different routes of misoprostol administration before operative hysteroscopy: a randomized, controlled trial.
95
ÇØ¿Ü
Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
1
2
3
4
5
6
7
8
9
10
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729